SSY GROUP(02005): Nifedipine hydrochloride has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.
Shi Si Medicine Group (02005) has issued an announcement that the group's Nifedipine hydrochloride has been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's Nicardipine Hydrochloride has been approved for registration by the China National Medical Products Administration as an active pharmaceutical ingredient for use in marketed preparations. Nicardipine Hydrochloride is mainly used for the treatment of high blood pressure.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
